Cargando…

Prostate cancer antigen 3 and genetic risk score as markers for the detection of prostate cancer in the Chinese population

Detalles Bibliográficos
Autores principales:	Wei, Han-Min, Chen, Hai-Tao, Wang, Ping, Wu, Yi-Shuo, Na, Rong, Liu, Fang, Sun, Ji-Shan, Jiang, De-Ke, Lu, Da-Ru, Xu, Jianfeng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Medknow Publications & Media Pvt Ltd 2015
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4291867/ https://www.ncbi.nlm.nih.gov/pubmed/25412674 http://dx.doi.org/10.4103/1008-682X.143245

Ejemplares similares

Evaluation of PSA-age volume score in predicting prostate cancer in Chinese population
por: Wu, Yi-Shuo, et al.
Publicado: (2018)

Re: Prognosis of prostate cancer and prostate - specific antigen levels
por: Joob, Beuy, et al.
Publicado: (2019)

Prostate specific antigen change after administration of nimotuzumab in prostate cancer
por: Chaiyasit, Kamon, et al.
Publicado: (2013)

Age-Specific Prostate Specific Antigen Cutoffs for Guiding Biopsy Decision in Chinese Population
por: Na, Rong, et al.
Publicado: (2013)

Prostate-specific antigen for prediction of skeletal metastases on bone scintigraphy in prostate cancer
por: Hammond, Emmanuel Nii Boye, et al.
Publicado: (2021)

Clinical evaluation of prostate cancer gene 3 score in diagnosis among Chinese men with prostate cancer and benign prostatic hyperplasia
por: Huang, Jin, et al.
Publicado: (2015)

Outcomes and Trends of Prostate Biopsy for Prostate Cancer in Chinese Men from 2003 to 2011
por: Na, Rong, et al.
Publicado: (2012)

Plasma genistein and risk of prostate cancer in Chinese population
por: Wu, Yishuo, et al.
Publicado: (2015)

The influence of prostate volume on cancer detection in the Chinese population
por: Wu, Yi-Shuo, et al.
Publicado: (2014)

Clinical validity and utility of genetic risk scores in prostate cancer
por: Helfand, Brian T, et al.
Publicado: (2016)

Germline mutations in 5’ to c.7914 of BRCA2 significantly increase risk of prostate cancer
por: Ruan, Xiao-Hao, et al.
Publicado: (2022)

Prostate Cancer and Cardiovascular Risk Factors
por: Lin, Cha-An, et al.
Publicado: (2023)

The Combined Effect of Polygenic Risk Score and Prostate Health Index in Chinese Men Undergoing Prostate Biopsy
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Beyond the Gleason score: the prognostic significance of prostate cancer subtypes
por: Flood, Trevor A., et al.
Publicado: (2018)

Influence of age on predictiveness of genetic risk score for prostate cancer in a Chinese hospital-based biopsy cohort
por: Zhu, Yao, et al.
Publicado: (2015)

The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer
por: Xu, Jianfeng
Publicado: (2014)

Genetic risk assessment of lethal prostate cancer using polygenic risk score and hereditary cancer susceptibility genes
por: Ruan, Xiaohao, et al.
Publicado: (2023)

Single-Nucleotide Polymorphism–Based Genetic Risk Score and Patient Age at Prostate Cancer Diagnosis
por: Na, Rong, et al.
Publicado: (2019)

Population-standardized genetic risk score: the SNP-based method of choice for inherited risk assessment of prostate cancer
por: Conran, Carly A, et al.
Publicado: (2016)

Detection of Prostate Cancer Antigen 3 and Prostate Cancer Susceptibility Candidate in Non-DRE Urine Improves Diagnosis of Prostate Cancer in Chinese Population
por: Ye, Lie-Fu, et al.
Publicado: (2020)

Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy
por: Wang, Fu-Bo, et al.
Publicado: (2017)

Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer
por: Lehrer, S, et al.
Publicado: (2002)

A urine extracellular vesicle circRNA classifier for detection of high-grade prostate cancer in patients with prostate-specific antigen 2–10 ng/mL at initial biopsy
por: He, Ya-Di, et al.
Publicado: (2021)

Our experiences and suggestions with PEEK marker use in prostate cancer radiotherapy
por: Sen, Cenk Ahmet
Publicado: (2018)

Phi-based risk calculators performed better in the prediction of prostate cancer in the Chinese population
por: Wu, Yi-Shuo, et al.
Publicado: (2019)

The performance characteristics of prostate-specific antigen and prostate-specific antigen density in Chinese men
por: Teoh, Jeremy YC, et al.
Publicado: (2017)

Standardised Uptake Value in Organ Confined Prostate Cancer in 68-Ga- Prostate-Specific Membrane Antigen Positron Emission Tomography-Computed Tomography Scan and its Correlation with Prostate Specific Antigen Level and Gleason Score
por: Ali*, Haider, et al.
Publicado: (2023)

PSA density in the diagnosis of prostate cancer in the Chinese population: results from the Chinese Prostate Cancer Consortium
por: Song, Zi-Jian, et al.
Publicado: (2020)

The Diagnosis of Prostate Cancer
por: Schulz, Robert J.
Publicado: (2016)

Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Cancer Antigen 125, Prostate-Specific Antigen and Other Cancer Markers: A Primer on Commonly Used Cancer Markers
por: Desai, Shreya, et al.
Publicado: (2023)

Effect of Obesity on Prostate-Specific Antigen, Prostate Volume, and International Prostate Symptom Score in Patients with Benign Prostatic Hyperplasia
por: Kim, Jong Min, et al.
Publicado: (2011)

Genetic Variant as a Selection Marker for Anti–Prostate Stem Cell Antigen Immunotherapy of Bladder Cancer
por: Kohaar, Indu, et al.
Publicado: (2013)

Prostate Health Index (phi) and its derivatives predict Gleason score upgrading after radical prostatectomy among patients with low-risk prostate cancer
por: Yan, Jia-Qi, et al.
Publicado: (2021)

Prostate cancer polygenic risk score and prediction of lethal prostate cancer
por: Klein, Robert J., et al.
Publicado: (2022)

Prostate volume does not provide additional predictive value to prostate health index for prostate cancer or clinically significant prostate cancer: results from a multicenter study in China
por: Huang, Da, et al.
Publicado: (2020)

Significant Diagnostic Value of Free-Serum PSA (FPSA)/Prostate-Specific Antigen Density (PSAD) and (F/T)/PSAD for Prostate Cancer of the Chinese Population in a Single Institution
por: Nan, Li-Bin, et al.
Publicado: (2019)

Inflammatory Genetic Markers of Prostate Cancer Risk
por: Tindall, Elizabeth A., et al.
Publicado: (2010)

Serum Early Prostate Cancer Antigen (EPCA) Level and Its Association with Disease Progression in Prostate Cancer in a Chinese Population
por: Zhao, Zhigang, et al.
Publicado: (2011)

Percent free prostate-specific antigen is effective to predict prostate biopsy outcome in Chinese men with prostate-specific antigen between 10.1 and 20.0 ng ml(−1)
por: Chen, Rui, et al.
Publicado: (2015)

Updates of prostate cancer staging: Prostate-specific membrane antigen
por: Sathianathen, Niranjan J, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_9org805c8fi4ukulmsc9es6057